What is the current Colorectal Cancer Diagnostics market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Colorectal Cancer Diagnostics market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the major challenges facing the Colorectal Cancer Diagnostics market?

High costs of diagnostic tests and lack of awareness in developing regions are major challenges.

Which regions are leading the Colorectal Cancer Diagnostics market?

North America and Europe are leading the market due to high healthcare expenditure.

Who are the top companies in the Colorectal Cancer Diagnostics market?

Top companies include Roche, Abbott, and Siemens, offering innovative diagnostic solutions.

What are the future opportunities in the Colorectal Cancer Diagnostics market?

Emerging markets and advancements in AI-based diagnostics offer significant future opportunities.

How is technology impacting the Colorectal Cancer Diagnostics market?

Technological advancements in genetic testing and liquid biopsies are transforming the market.

What is the current regulatory landscape for the Colorectal Cancer Diagnostics market?

Stringent regulatory frameworks and reimbursement policies influence the market growth.

What is the future outlook for the Colorectal Cancer Diagnostics market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Colorectal Cancer Diagnostics Value Chain Analysis & Forecast Outlook 2033

Colorectal Cancer Diagnostics by Application (Hospitals, Specialty Clinics, Others), by Types (FOB Tests, CTC Tests, CEA Tests, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $13450 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $13450 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Colorectal Cancer Diagnostics Market Size | CAGR 7.8 Forecast 2033

Colorectal Cancer Diagnostics Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $13450 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $13450 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Colorectal Cancer Diagnostics Market Overview

The Colorectal Cancer Diagnostics market refers to the industry focused on developing and marketing diagnostic tests and tools for the detection and monitoring of colorectal cancer. As the Colorectal Cancer Diagnostics market size is expected to experience significant growth, driven by an increasing incidence of colorectal cancer and advancements in diagnostic technologies, the growth outlook for this market is promising. The market forecast indicates a substantial expansion, with the global Colorectal Cancer Diagnostics market estimated to be around $8.7 billion in 2025. The industry expansion is expected to be driven by factors such as technological advancements, increasing awareness about colorectal cancer, and growing demand for early detection and treatment.

Loading chart…

The Colorectal Cancer Diagnostics market is expected to experience a growth forecast with a CAGR of around 7.5% during the forecast period, driven by macro drivers such as technological advancements, increasing awareness about colorectal cancer, and growing demand for early detection and treatment. Key forces shaping the industry include technology shifts towards non-invasive and minimally invasive diagnostic tests, regulations supporting the development and approval of new diagnostic tests, and consumer behavior driving demand for early detection and treatment. The largest region in the Colorectal Cancer Diagnostics market is expected to be North America, while the fastest-growing region is expected to be Asia-Pacific. The market is expected to be driven by the increasing incidence of colorectal cancer, advancements in diagnostic technologies, and growing demand for early detection and treatment.

Report Overview

Report Attribute	Details
Market size value in 2025	13.45 billion
Revenue forecast in 2033	24.53 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biocept; Cancer Genetics; Foundation Medicine; Sysmex Corporation; Danaher Corporation; Epigenomics; Illumina; Rosetta Genomics; Exact Science Corporation; Pathway Genomics Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Colorectal Cancer Diagnostics market is witnessing significant growth, driven by increasing awareness and advancements in diagnostic technologies. The Colorectal Cancer Diagnostics market size is expected to expand substantially, with a promising growth forecast. This section outlines the key dynamics influencing the market.

Growth Drivers2 items

Advances in non-invasive diagnostic techniques, such as stool-based tests and blood-based biomarkers, are driving the adoption of Colorectal Cancer Diagnostics solutions, contributing to the growth of the Colorectal Cancer Diagnostics market size.

Increasing screening initiatives and awareness campaigns by governments and healthcare organizations are fueling the demand for Colorectal Cancer Diagnostics, thereby supporting the overall growth forecast of the market.

Restraints2 items

High costs associated with advanced diagnostic tests and equipment are limiting the accessibility of Colorectal Cancer Diagnostics solutions, particularly in low-income countries, which can hinder the growth of the Colorectal Cancer Diagnostics market size.

Stringent regulatory requirements and reimbursement challenges are restraining the growth of new entrants in the Colorectal Cancer Diagnostics market, affecting the overall growth forecast.

Opportunities2 items

Emerging economies present significant opportunities for the Colorectal Cancer Diagnostics market, driven by increasing healthcare expenditure and a rising demand for cancer diagnostics solutions, which can contribute to the growth forecast of the market.

The integration of artificial intelligence and machine learning in Colorectal Cancer Diagnostics is expected to improve diagnostic accuracy and efficiency, creating new opportunities for market players and driving the growth of the Colorectal Cancer Diagnostics market size.

Challenges2 items

The Colorectal Cancer Diagnostics market faces challenges related to data privacy and security, particularly with the increasing use of digital platforms for diagnostic data storage and analysis, which can impact the growth forecast of the market.

Intense competition among market players, coupled with pricing pressures, can hinder the growth of the Colorectal Cancer Diagnostics market size and affect the overall growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment in the Colorectal Cancer Diagnostics market refers to the various uses of diagnostic tests and tools for detecting and monitoring colorectal cancer. This segment contributes significantly to the overall market size, as it encompasses a wide range of applications, including screening, diagnosis, and disease monitoring. The Colorectal Cancer Diagnostics segmentation by application is crucial in understanding the market dynamics, as it helps identify the most prominent areas of application and their corresponding market shares.

The Types segment in the Colorectal Cancer Diagnostics market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy, as it allows for a detailed analysis of each subtype's contribution to the overall market size. The types of diagnostic tests and tools available for colorectal cancer diagnostics play a vital role in shaping the market landscape, and understanding these subtypes is crucial for industry stakeholders to make informed decisions.

Colorectal Cancer Diagnostics Segmentation Breakdown9 items

Application

Hospitals

Specialty Clinics

Others

Types

FOB Tests

CTC Tests

CEA Tests

Others

Regional Insights

Loading chart…

The Colorectal Cancer Diagnostics market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the global market, driven by key drivers such as high adoption of advanced diagnostic technologies, favorable policies supporting cancer research, and significant investments in healthcare infrastructure.

The Asia Pacific region is the fastest-growing, with a regional forecast indicating a significant increase in market share. Key drivers for this region include growing demographics with an increasing elderly population, improving infrastructure with modernized healthcare facilities, and expanding ecosystem maturity with rising awareness about colorectal cancer.

In Europe, key drivers include established healthcare systems, high awareness about colorectal cancer, and strong research initiatives. Latin America is driven by government initiatives to improve healthcare access, growing demand for cancer diagnostics, and increasing investments in medical technology. The Middle East & Africa region is driven by growing healthcare expenditure, rising cancer incidence, and expanding medical tourism.

Competitive Landscape

The Colorectal Cancer Diagnostics market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Colorectal Cancer Diagnostics competitive landscape is driven by the need for accurate and reliable diagnostic tests, with key players focusing on developing innovative products and expanding their distribution networks. Global players are leveraging their scale and resources to drive growth, while local companies are competing on the basis of regional expertise and customization.

Companies in the Colorectal Cancer Diagnostics market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantages. To overcome these challenges, companies are focusing on developing unique technologies, service models, and channel strengths, as well as offering customized solutions and cost advantages.

Biocept: regional expansion

Cancer Genetics: innovation pipeline

Foundation Medicine: premium pricing

Sysmex Corporation: OEM tie-ups

Danaher Corporation: vertical integration

Epigenomics: local manufacturing

Key Colorectal Cancer Diagnostics Companies10 items

Biocept

Cancer Genetics

Foundation Medicine

Sysmex Corporation

Danaher Corporation

Epigenomics

Illumina

Rosetta Genomics

Exact Science Corporation

Pathway Genomics Corporation

Market Ecosystem

The Colorectal Cancer Diagnostics ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of diagnostic products and services. Understanding the Colorectal Cancer Diagnostics ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — providing chemical reagents

Technology providers — developing diagnostic platforms

OEMs / manufacturers — producing diagnostic equipment

System integrators / EPCs — integrating diagnostic systems

Distributors / channel partners — supplying diagnostic products

Service providers / after-sales — offering maintenance services

Regulators/standards bodies — establishing diagnostic standards

The flow of value within the Colorectal Cancer Diagnostics ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can impact the adoption of diagnostic products and services. Moreover, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The ecosystem's dynamics can differ by region, with varying levels of access to diagnostic technologies and services.

Recent Industry Insights

The Colorectal Cancer Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been several strategic partnerships, such as collaborations between diagnostic companies and research institutions, aimed at advancing the field of colorectal cancer detection. Furthermore, the industry has seen a surge in innovative product launches, including non-invasive testing kits and advanced imaging technologies, which are expected to drive growth in the market. Additionally, regulatory changes, such as the approval of new diagnostic tests, have also contributed to the evolution of the Colorectal Cancer Diagnostics landscape.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Colorectal Cancer Diagnostics market. The market attractiveness is moderate, driven by increasing awareness and advancements in diagnostic technologies. The competitive intensity is high, with key players investing heavily in research and development. The long-term outlook for the Colorectal Cancer Diagnostics market outlook is promising, with a growing demand for non-invasive diagnostic tests.

The innovation landscape is evolving, with a focus on liquid biopsies and artificial intelligence-powered diagnostic tools. However, the demand-supply balance is a concern, with a shortage of skilled professionals and high equipment costs. Key risk factors include regulatory changes, reimbursement issues, and the emergence of new diagnostic technologies that may disrupt the market.

11 items

1. Executive Summary

2. Colorectal Cancer Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Colorectal Cancer Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Colorectal Cancer Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Specialty Clinics

6.1.3. Others

6.2. Global Colorectal Cancer Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. FOB Tests

6.2.2. CTC Tests

6.2.3. CEA Tests

6.2.4. Others

6.3. Global Colorectal Cancer Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Colorectal Cancer Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Colorectal Cancer Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Colorectal Cancer Diagnostics Market Competition by Key Manufacturers

8.1. Global Colorectal Cancer Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Colorectal Cancer Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biocept

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cancer Genetics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Foundation Medicine

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sysmex Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Epigenomics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Illumina

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Rosetta Genomics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Exact Science Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Pathway Genomics Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Colorectal Cancer Diagnostics Market

Figure 4: Global Colorectal Cancer Diagnostics Market: Drivers

Figure 5: Global Colorectal Cancer Diagnostics Market: Challenges

Figure 6: Global Colorectal Cancer Diagnostics Market: Trends

Figure 7: Global Colorectal Cancer Diagnostics Market: Opportunity

Figure 8: Global Colorectal Cancer Diagnostics Market: Restraint

Figure 9: Global Colorectal Cancer Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Colorectal Cancer Diagnostics Market Value (USD Million) By Region

Figure 15: Global Colorectal Cancer Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Colorectal Cancer Diagnostics Market Value (USD Million) By Region

Figure 23: Global Colorectal Cancer Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Colorectal Cancer Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Colorectal Cancer Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Colorectal Cancer Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Colorectal Cancer Diagnostics Market Value (USD Million) By Region

Table 10: Global Colorectal Cancer Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Colorectal Cancer Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Colorectal Cancer Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Colorectal Cancer Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biocept Basic Information And Sales Area

Table 31: Biocept. Products Portfolio

Table 32: Cancer Genetics Basic Information And Sales Area

Table 33: Cancer Genetics. Products Portfolio

Table 34: Foundation Medicine Basic Information And Sales Area

Table 35: Foundation Medicine. Products Portfolio

Table 36: Sysmex Corporation Basic Information And Sales Area

Table 37: Sysmex Corporation. Products Portfolio

Table 38: Danaher Corporation Basic Information And Sales Area

Table 39: Danaher Corporation. Products Portfolio

Table 40: Epigenomics Basic Information And Sales Area

Table 41: Epigenomics. Products Portfolio

Table 42: Illumina Basic Information And Sales Area

Table 43: Illumina. Products Portfolio

Table 44: Rosetta Genomics Basic Information And Sales Area

Table 45: Rosetta Genomics. Products Portfolio

Table 46: Exact Science Corporation Basic Information And Sales Area

Table 47: Exact Science Corporation. Products Portfolio

Table 48: Pathway Genomics Corporation Basic Information And Sales Area

Table 49: Pathway Genomics Corporation. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Colorectal Cancer Diagnostics Market Value (USD Million) By Region

Table 55: Global Colorectal Cancer Diagnostics Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Colorectal Cancer Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	13.45 billion
Revenue forecast in 2033	24.53 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biocept; Cancer Genetics; Foundation Medicine; Sysmex Corporation; Danaher Corporation; Epigenomics; Illumina; Rosetta Genomics; Exact Science Corporation; Pathway Genomics Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options